Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 272

Results For "PLI"

2759 News Found

Prime Minister holds high level meeting on oxygen
News | April 23, 2021

Prime Minister holds high level meeting on oxygen

Against the present demand from 20 states of 6,785 MT/day of Liquid Medical Oxygen, the Government of India has from 21st April allocated 6,822 MT/day to these states


Pharma and medical device to play a pivotal role: Gowda
News | April 21, 2021

Pharma and medical device to play a pivotal role: Gowda

The Department of Pharmaceuticals launched the PLI scheme for promoting domestic manufacturing of bulk drugs, with a financial outlay of Rs. 6,940 crore across 53 APIs over 6 years


Glenmark Life Sciences files for IPO
News | April 18, 2021

Glenmark Life Sciences files for IPO

The IPO comprises a fresh issue of up to Rs. 11,600 million and an offer for sale of up to 7,305,245 equity shares of Rs. 2 each of Glenmark Life Sciences by Glenmark Pharmaceuticals


Merck publishes sustainability report for 2020
News | April 13, 2021

Merck publishes sustainability report for 2020

The company is pursuing specific goals in the areas of science and technology, value chain as well as climate and the environment.


NATCO receives approval for Ibrutinib tablets from ANDA
News | April 11, 2021

NATCO receives approval for Ibrutinib tablets from ANDA

The approval is for Ibrutinib tablets 560 mg, 420 mg, 280 mg and 140 mg strengths


Aurore to merge with Solara in an all-stock transaction
News | April 10, 2021

Aurore to merge with Solara in an all-stock transaction

The merger is in line with Solara’s strategy of accelerating growth via appropriate inorganic actions


Pharma sector has both brainpower and manpower to drive growth: Mandaviya
Policy | April 09, 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable


Zydus Cadila announces USFDA approval for Ibrutinib capsules
News | April 08, 2021

Zydus Cadila announces USFDA approval for Ibrutinib capsules

Zydus was the first ANDA applicant to submit a substantially complete ANDA with a paragraph IV certification for Ibrutinib Capsules, 70 mg.


Panacea to produce 100 mn doses of Sputnik V vaccine
News | April 06, 2021

Panacea to produce 100 mn doses of Sputnik V vaccine

Production of Sputnik V at Panacea Biotec sites will help facilitate global supply of Sputnik V to international partners of RDIF


Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities
News | April 05, 2021

Piramal Enterprises forays into peptide with Hemmo Pharma : ICICI Securities

ICICI Securities expects Hemmo to grow its revenue at a CAGR of 30.0% over FY21E-FY23E